JPH0428020B2 - - Google Patents
Info
- Publication number
- JPH0428020B2 JPH0428020B2 JP61054335A JP5433586A JPH0428020B2 JP H0428020 B2 JPH0428020 B2 JP H0428020B2 JP 61054335 A JP61054335 A JP 61054335A JP 5433586 A JP5433586 A JP 5433586A JP H0428020 B2 JPH0428020 B2 JP H0428020B2
- Authority
- JP
- Japan
- Prior art keywords
- polylactide
- aluminum
- reaction
- present
- porous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 25
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 21
- 229920000954 Polyglycolide Polymers 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 238000013268 sustained release Methods 0.000 description 11
- 239000012730 sustained-release form Substances 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- -1 etc. Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001432 poly(L-lactide) Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 3
- 229940039790 sodium oxalate Drugs 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 2
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- 235000010893 Bischofia javanica Nutrition 0.000 description 1
- 240000005220 Bischofia javanica Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229940083916 aluminum distearate Drugs 0.000 description 1
- KMJRBSYFFVNPPK-UHFFFAOYSA-K aluminum;dodecanoate Chemical compound [Al+3].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O KMJRBSYFFVNPPK-UHFFFAOYSA-K 0.000 description 1
- JJCSYJVFIRBCRI-UHFFFAOYSA-K aluminum;hexadecanoate Chemical compound [Al].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O JJCSYJVFIRBCRI-UHFFFAOYSA-K 0.000 description 1
- RDIVANOKKPKCTO-UHFFFAOYSA-K aluminum;octadecanoate;hydroxide Chemical compound [OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O RDIVANOKKPKCTO-UHFFFAOYSA-K 0.000 description 1
- HSMXEPWDIJUMSS-UHFFFAOYSA-K aluminum;tetradecanoate Chemical compound [Al+3].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O HSMXEPWDIJUMSS-UHFFFAOYSA-K 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- IUWVALYLNVXWKX-UHFFFAOYSA-N butamben Chemical compound CCCCOC(=O)C1=CC=C(N)C=C1 IUWVALYLNVXWKX-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- VAROLYSFQDGFMV-UHFFFAOYSA-K di(octanoyloxy)alumanyl octanoate Chemical compound [Al+3].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O VAROLYSFQDGFMV-UHFFFAOYSA-K 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- MAQCMFOLVVSLLK-UHFFFAOYSA-N methyl 4-(bromomethyl)pyridine-2-carboxylate Chemical compound COC(=O)C1=CC(CBr)=CC=N1 MAQCMFOLVVSLLK-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000003516 soil conditioner Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- CRHIAMBJMSSNNM-UHFFFAOYSA-N tetraphenylstannane Chemical compound C1=CC=CC=C1[Sn](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 CRHIAMBJMSSNNM-UHFFFAOYSA-N 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
(産業上の利用分野)
本発明は多孔性基剤に関し、殊に薬剤等を基剤
に含浸させた際に薬剤の優れた徐放特性を付与す
る多孔性基剤の製造方法に関する。
乳酸、グリコール酸等の重合体、即ちポリラク
チド、ポリグリコリドは生体内分解性のポリマー
として、近年縫合糸、人工気管、人工血管等の医
用インプラント材料に応用されている。また一方
で、生理活性物質、農薬等の薬剤の徐放化基剤と
しての応用もされつつある。
これらの材料に所望される特性として、生体親
和性、生体内分解性等を有することだけでなく、
薬剤等を含浸した材料については一定期間内に薬
剤を基剤から放出するという徐放制御が課題とな
つている。
この新しい展開として、近年ポリラクチド等の
徐放化、即ち多孔質化が検討されている。
(従来の技術)
従来、ポリラクチドを多孔質化する方法とし
て、クロロホルム−エタノール等の特定混合溶媒
にポリラクチドとシユウ酸ナトリウムを溶解し、
この溶媒を一定速度で蒸発させた後、シユウ酸ナ
トリウムをエタノールで抽出することにより得る
方法が知られている。(Penningsら、Colloid.
polym.Sci.、261、477(1983))
しかしこの方法は、溶媒の蒸発速度の制御が非
常に難しく、所望する孔径のポリマーが得られな
い。また添加したシユウ酸ナトリウム等の塩がポ
リマー中に残留し、生体系への使用用途が制約さ
れる。
また別に、低分子量のポリラクチドとクロム、
アルミニウム等の塩化物、炭酸塩とを約260〜280
℃という高温で反応させ樹脂を製造する方法が知
られているが、この方法は反応に極めて長時間を
要し、ポリラクチドの分解を促進し、反応生成物
中に分解物が多量に残存する。そしてこのものは
低分子量、低強度であることから、多孔性基剤と
して通常使用できないものである。
又別に、高級脂肪酸のアルカリ土類金属塩又は
アルミニウム塩等とポリラクチド等を溶媒に溶解
し、繊維に被覆し、繊維表面の改質を行う方法が
知られている。(特開昭53−83381号)
しかしこの方法は、繊維の改質に通常使用され
る高級脂肪酸塩の改質を目的とするものであり、
高級脂肪酸を多含し、また高分子量のポリラクチ
ド等を使用することから、本発明の様な反応を生
起せず、以つて多孔質体とはなり得ず、ポリラク
チドは単に少量混合されているに溜まり、本発明
の多孔質体とは全く別異のものである。
このようにポリラクチド、ポリグリコリド等か
らなる多孔性基剤として、未だ徐放性、基剤強度
等に優れる基剤を得る方法は見出されていないの
が現状である。
(発明が解決しようとする問題点)
そこで本発明者らは、前記の問題を解決すべく
多孔性基剤として孔径の制御が容易であり、しか
も基剤としての強度、徐放特性に優れるポリラク
チドまたはポリグリコリドからなる多孔性基剤を
得る方法につき鋭意研究を進めた。
(問題点を解決するための手段)
本発明者らは種々の検討を行なつた結果、有機
溶媒中でポリラクチド、ポリグリコリド、又はそ
れらの共重縮合体と、ステアリン酸アルミニウム
等の炭素数8以上の高級脂肪酸のアルミニウム塩
とを反応させることにより、ポリラクチド、ポリ
グリコリド、又はそれらの共重縮合体を所望する
孔径に多孔質化でき、しかもこの反応は室温程度
の温度で短時間に行なえることを見い出し、その
結果、初期のポリマー分子量の低下が回避され、
徐放性、強度特性共に優れる多孔性基剤を得るこ
とが可能になり、本発明を完成したものである。
即ち本発明は、有機溶媒中で数平均分子量が
500〜15000のポリラクチド、ポリグリコリド、又
はそれらの共重縮合体と、炭素数8以上の高級脂
肪酸のアルミニウム塩とを、前記ポリマー量に対
してアルミニウム塩量が3〜20重量%の範囲とな
るように添加し、反応させてなる多孔性基剤に関
する。
(作用)
本発明の多孔性基剤の製造に用いる原料とし
て、先ずポリラクチド、ポリグリコリド、又はそ
れらの共重縮合体については、これらは一般的な
方法により製造されるものであれば何れのもので
あつてもよい。
例えば、乳酸、グリコール酸を減圧下で直接脱
水重縮合を行なうことによりポリラクチド、ポリ
グリコリドが得られる。(湯原ら、工化.67(6)、
956(1964))
また、乳酸、グリコール酸を酸化亜鉛等の触媒
存在下で縮合を行ない、ラクチド、グリコリドを
得た後、これをテトラフエニルスズ、塩化第1ス
ズ等の触媒存在下で重合反応を行なうことによつ
ても製造できる。(Kulkarni、J.Biomed.Mater.
Res.、、5、169(1971))
更に、これらの場合に使用する乳酸のモノマー
は、D−体、L−体、及びDL−体の各れのもの
であつてもよい。
本発明ではこの様にして得られるポリラクチド
またはポリグリコリドの数平均分子量が500〜
1500のものを使用する。
即ち、この範囲を逸脱する分子量のポリマーの
使用では、本発明の多孔性基剤を得ることができ
ない。
分子量がこの範囲を逸脱し、500を下回る場合
には、基剤の孔径が過大となり過ぎ基剤の強度が
低下し、また逆に、15000を上回る場合には、後
述するポリマーとアルミニウム塩との反応性が低
下すると共に基剤の孔径が過小となり、本発明の
多孔性基剤を得ることが困難となる。従つて、使
用するポリラクチド、ポリグリコリド、又はそれ
らの共重縮合体のこの分子量の範囲は、本発明に
於て殊に重要である。
次に、本発明で用いる有機溶媒に関して云え
ば、前記のポリラクチド、ポリグリコリド、又は
それらの共重縮合体を溶解する有機溶媒であれば
何であつてもよく、クロロホルム、四塩化炭素、
ベンゼン、トルエン、ジオキサン等、更にはイソ
プロパノール、ブタノール等のアルコール類、及
びアセトン等が使用できる。
また、炭素数8以上の高級脂肪酸のアルミニウ
ム塩としては、ステアリン酸アルミニウム、パル
ミチン酸アルミニウム、ラウリン酸アルミニウ
ム、ミリスチン酸アルミニウム、オクチル酸アル
ミニウム、オレイン酸アルミニウム、ソルビタン
モノオレイン酸アルミニウム、ソルビタンモノス
テアリン酸アルミニウム、ケイヒ酸アルミニウ
ム、3−フエニルプロピオン酸アルミニウム等を
例示することができる。
これら炭素数8以上の高級脂肪酸のアルミニウ
ム塩以外の他のアルミニウム塩の使用では、本発
明の反応が起こらず、または反応しても多孔質体
が生起せず、以つて本発明の多孔質体を得ること
ができない。
これらの原料を使用し、本発明の多孔性基剤を
製造する方法は次のように行なう。
先ず、ポリラクチド、ポリグリコリド、又はそ
れらの共重縮合体を前記の有機溶媒に溶解する。
この時のこれらポリマーの濃度は、その分子量、
所望する基剤の孔径等によつて異なるが、大略3
〜40重量%の範囲で使用する。
即ち、この時のポリマー分子量及びポリマー濃
度の選択により、本発明では自由に多孔性基剤の
孔径を調整することができる。
このポリマーの濃度を高く、または分子量が高
いものを使用するほど基剤孔径は小さくなり、ま
た反対にポリマー濃度を低く、または分子量が低
いものを使用する程、基剤の孔径は大きくなる。
次に前記に掲げた炭素数8以上の高級脂肪酸の
アルミニウム塩を、同様に有機溶媒に溶解または
懸濁させる。この場合に、これらアルミニウム塩
の濃度は、概ね50重量%までの範囲で溶解又は懸
濁させる。
有機溶媒に溶解したポリラクチド、ポリグリコ
リド、又はそれらの共重縮合体と前記のアルミニ
ウム塩との反応は、先ず前記のポリマーの溶液を
反応容器に入れ、次にアルミニウム塩溶液を撹は
んしながら添加する。
この場合に、添加順序について別段限定はな
く、アルミニウム塩を先に、又はポリマーとアル
ミニウム塩とを同時に添加する方法によつてもよ
い。更に、この時の両者の添加割合は、反応に用
いるポリラクチド、ポリグリコリド、又はそれら
の共重縮合体の分子量、また使用する炭素数8以
上の高級脂肪酸のアルミニウム塩の種類等により
異なるが、前記ポリマー量に対してアルミニウム
塩量が3〜20重量%の範囲となるように使用す
る。
即ち、この範囲を逸脱する基剤は多孔質化せ
ず、以つて本発明の多孔性基剤を得ることができ
ない。
反応時の溶液の温度は通常室温でよいが、適度
な加温を行つてもよい。
反応の進行と共に反応液はゲル化するが、反応
開始時より通常2時間程度で反応は終了する。反
応の終了後、得られるゲル状物をメタノール、エ
タノール、エーテル等の溶媒で溶媒析出処理し、
乾燥を行なうか、あるいはゲル状物を直接減圧乾
燥することにより、本発明の多孔性基剤を得るこ
とが出来る。
この様にして得られた本発明の基剤は、多孔質
であり、基剤としての強度特性に優れ、またポリ
ラクチド、ポリグリコリド、又はそれらの共重縮
合体を基剤の主体とするため、基剤自体の徐放性
との共同作用により徐放性が著しく増加し、徐放
性基剤として具有すべき優れた徐放特性を有する
ものである。
従つて本発明品は、薬剤等のマトリツクス、イ
ンプラント材料のみならず、菌体、微生物の保持
剤、マイクロカプセルとしての担体、土壌改良
剤、崩壊性農業用フイルム、果実の品質向上剤、
気体分離透過膜、芳香剤等、幅広い用途に用いる
ことができる。
(実施例)
以下に本発明の実施例を掲げ説明を行なうが、
本発明はこれらに限定されるものではない。尚、
%は特にことわらない限り全て重量%を示す。
実施例 1
数平均分子量760のポリ−L−ラクチド及びモ
ノステアリン酸アルミニウムを、各々第1表に示
す割合でクロロホルムに加熱溶解又は分散させ
た。
このポリ−L−ラクチドのクロロホルム溶液
を、温度計、撹はん機、コンデンサーを備えた
300ml容のセパラブルフラスコに入れ、40℃に加
温し、撹はんを行いながら、モノステアリン酸ア
ルミニウムのクロロホルム分散液を添加した。
モノステアリン酸アルミニウムの添加後数分で
反応系がゲル化するが、これに更に40gのクロロ
ホルムを添加し、開始後12分で撹はんを止め、生
成物をフラスコから取り出した。
反応生成物を40℃7mmHgで減圧乾燥し、本発
明の多孔性基剤等を得た。
これらを走査型電子顕微鏡で生成物の多孔性状
態を観察し、その結果を第1表に示した。
更に、反応乾燥後に得た本発明品、及び比較例
品について、ジオキサン吸収量を測定し、基剤の
多孔質化度をみた。結果を第1表に示した。
<ジオキサン吸収量の測定法>
基剤試料の2gを300ml容のビーカーに入れ、
これに200gのジオキサンを添加し、24時間浸漬
させた。浸漬後、余分のジオキサンを除去した
後、ろ紙上で1時間風乾し、これの重量を測定
し、次式によりジオキサン吸収量を算出した。
X=W2−W1/W1(g/g)
但し、
X:ジオキサン吸収量(g/g)
W1:試料採取量(g)
W2:ジオキサン吸収後の試料重量(g)
(Industrial Application Field) The present invention relates to a porous base, and more particularly to a method for producing a porous base that imparts excellent sustained release characteristics of a drug when the base is impregnated with a drug. Polymers such as lactic acid and glycolic acid, ie, polylactide and polyglycolide, are biodegradable polymers that have recently been applied to medical implant materials such as sutures, artificial tracheas, and artificial blood vessels. On the other hand, it is also being applied as a sustained release base for drugs such as physiologically active substances and agricultural chemicals. Desired properties for these materials include not only biocompatibility and biodegradability, but also
For materials impregnated with drugs, etc., sustained release control, in which the drug is released from the base within a certain period of time, is an issue. As a new development, in recent years, sustained release of polylactide and the like, that is, making it porous, has been studied. (Prior art) Conventionally, as a method of making polylactide porous, polylactide and sodium oxalate are dissolved in a specific mixed solvent such as chloroform-ethanol,
A known method is to evaporate the solvent at a constant rate and then extract sodium oxalate with ethanol. (Pennings et al., Colloid.
Polym. Sci., 261 , 477 (1983)) However, with this method, it is very difficult to control the evaporation rate of the solvent, and a polymer with the desired pore size cannot be obtained. Furthermore, added salts such as sodium oxalate remain in the polymer, which limits its use in biological systems. Separately, low molecular weight polylactide and chromium,
Approximately 260 to 280 chlorides and carbonates of aluminum, etc.
A method of producing resin by reacting at a high temperature of °C is known, but this method requires an extremely long time for the reaction, accelerates the decomposition of polylactide, and leaves a large amount of decomposed products in the reaction product. Since this material has a low molecular weight and low strength, it cannot normally be used as a porous base material. Another known method is to dissolve alkaline earth metal salts or aluminum salts of higher fatty acids, polylactide, etc. in a solvent, coat the fibers with the solution, and modify the fiber surface. (Japanese Patent Application Laid-open No. 53-83381) However, this method is aimed at modifying higher fatty acid salts that are normally used for modifying fibers.
Since polylactide containing a large amount of higher fatty acids and having a high molecular weight is used, the reaction as in the present invention does not occur and a porous body cannot be formed, and polylactide is simply mixed in a small amount. This is completely different from the porous body of the present invention. As described above, as a porous base made of polylactide, polyglycolide, etc., no method has yet been found to obtain a base having excellent sustained release properties, base strength, etc. (Problems to be Solved by the Invention) Therefore, in order to solve the above-mentioned problems, the present inventors developed polylactide, which is a porous base material whose pore diameter can be easily controlled, and which has excellent strength and sustained release properties as a base material. We also conducted intensive research on methods for obtaining porous bases made of polyglycolide. (Means for Solving the Problems) As a result of various studies, the present inventors found that polylactide, polyglycolide, or a copolycondensate thereof in an organic solvent and aluminum stearate having 8 carbon atoms, etc. By reacting the above higher fatty acids with aluminum salts, polylactide, polyglycolide, or their copolycondensates can be made porous to a desired pore size, and this reaction can be carried out in a short time at a temperature around room temperature. As a result, the initial decrease in polymer molecular weight was avoided,
It has become possible to obtain a porous base that is excellent in both sustained release properties and strength properties, thus completing the present invention. That is, in the present invention, the number average molecular weight is
500 to 15,000 polylactide, polyglycolide, or a copolycondensate thereof and an aluminum salt of a higher fatty acid having 8 or more carbon atoms, the amount of aluminum salt is in the range of 3 to 20% by weight based on the amount of the polymer. It relates to a porous base obtained by adding and reacting as described above. (Function) As raw materials for producing the porous base of the present invention, polylactide, polyglycolide, or their copolycondensates may be any polylactide, polyglycolide, or copolycondensate thereof, as long as they are produced by a general method. It may be. For example, polylactide and polyglycolide can be obtained by direct dehydration polycondensation of lactic acid and glycolic acid under reduced pressure. (Yubara et al., Koka. 67 (6),
956 (1964)) In addition, lactic acid and glycolic acid are condensed in the presence of a catalyst such as zinc oxide to obtain lactide and glycolide, which are then polymerized in the presence of a catalyst such as tetraphenyltin or stannous chloride. It can also be produced by conducting a reaction. (Kulkarni, J. Biomed. Mater.
Res., 5 , 169 (1971)) Furthermore, the lactic acid monomer used in these cases may be of the D-form, L-form, or DL-form. In the present invention, the number average molecular weight of polylactide or polyglycolide obtained in this way is 500 to 500.
Use the 1500 one. That is, if a polymer having a molecular weight outside this range is used, the porous base of the present invention cannot be obtained. If the molecular weight deviates from this range and is less than 500, the pore size of the base material becomes too large and the strength of the base material decreases, and conversely, if it exceeds 15,000, the combination of the polymer and aluminum salt described below As the reactivity decreases, the pore size of the base material becomes too small, making it difficult to obtain the porous base material of the present invention. Therefore, this molecular weight range of the polylactide, polyglycolide, or copolycondensate thereof used is particularly important in the present invention. Next, regarding the organic solvent used in the present invention, any organic solvent may be used as long as it dissolves the polylactide, polyglycolide, or copolycondensate thereof, such as chloroform, carbon tetrachloride,
Benzene, toluene, dioxane, etc., alcohols such as isopropanol, butanol, and acetone can be used. In addition, aluminum salts of higher fatty acids having 8 or more carbon atoms include aluminum stearate, aluminum palmitate, aluminum laurate, aluminum myristate, aluminum octylate, aluminum oleate, sorbitan aluminum monooleate, and sorbitan aluminum monostearate. , aluminum cinnamate, aluminum 3-phenylpropionate, and the like. When aluminum salts other than these aluminum salts of higher fatty acids having 8 or more carbon atoms are used, the reaction of the present invention does not occur, or even if the reaction occurs, a porous body is not generated. can't get it. The method for producing the porous base of the present invention using these raw materials is as follows. First, polylactide, polyglycolide, or a copolycondensate thereof is dissolved in the above-mentioned organic solvent.
The concentration of these polymers at this time is their molecular weight,
It varies depending on the pore size of the desired base material, etc., but approximately 3
Use in the range of ~40% by weight. That is, by selecting the polymer molecular weight and polymer concentration at this time, the pore diameter of the porous base material can be freely adjusted in the present invention. The higher the polymer concentration or the higher the molecular weight used, the smaller the base pore size becomes. Conversely, the lower the polymer concentration or the lower the molecular weight used, the larger the base pore size becomes. Next, the above-mentioned aluminum salt of higher fatty acid having 8 or more carbon atoms is similarly dissolved or suspended in an organic solvent. In this case, the concentration of these aluminum salts is generally dissolved or suspended in a range of up to 50% by weight. The reaction between polylactide, polyglycolide, or their copolycondensates dissolved in an organic solvent and the aluminum salt is carried out by first placing the polymer solution in a reaction vessel, and then stirring the aluminum salt solution. Added. In this case, there is no particular limitation on the order of addition, and the aluminum salt may be added first or the polymer and the aluminum salt may be added simultaneously. Furthermore, the ratio of addition of both at this time varies depending on the molecular weight of polylactide, polyglycolide, or their copolycondensate used in the reaction, the type of aluminum salt of higher fatty acid having 8 or more carbon atoms, etc. The amount of aluminum salt is used in a range of 3 to 20% by weight based on the amount of polymer. That is, a base material outside this range will not become porous, and the porous base material of the present invention cannot be obtained. The temperature of the solution during the reaction may normally be room temperature, but it may be heated appropriately. As the reaction progresses, the reaction solution turns into a gel, but the reaction usually ends within about 2 hours from the start of the reaction. After the reaction is completed, the resulting gel is subjected to solvent precipitation treatment with a solvent such as methanol, ethanol, or ether.
The porous base of the present invention can be obtained by drying or by directly drying the gel-like material under reduced pressure. The base material of the present invention obtained in this way is porous and has excellent strength properties as a base material, and since the base material is mainly polylactide, polyglycolide, or a copolycondensate thereof, The sustained release property is significantly increased due to the synergistic effect with the sustained release property of the base itself, and it has excellent sustained release properties that a sustained release base should have. Therefore, the product of the present invention can be used not only as a matrix for drugs, as an implant material, but also as a holding agent for bacterial cells and microorganisms, a carrier as a microcapsule, a soil conditioner, a disintegrating agricultural film, a fruit quality improver,
It can be used in a wide range of applications, such as gas separation permeable membranes and fragrance agents. (Example) Examples of the present invention will be described below, but
The present invention is not limited to these. still,
All percentages are by weight unless otherwise specified. Example 1 Poly-L-lactide and aluminum monostearate having a number average molecular weight of 760 were respectively dissolved or dispersed in chloroform in the proportions shown in Table 1. This chloroform solution of poly-L-lactide was prepared using a thermometer, a stirrer, and a condenser.
The mixture was placed in a 300 ml separable flask, heated to 40°C, and a chloroform dispersion of aluminum monostearate was added while stirring. The reaction system gelled several minutes after the addition of aluminum monostearate, to which 40 g of chloroform was further added, stirring was stopped 12 minutes after the start, and the product was taken out from the flask. The reaction product was dried under reduced pressure at 40° C. and 7 mmHg to obtain the porous base material of the present invention. The porous state of the products was observed using a scanning electron microscope, and the results are shown in Table 1. Furthermore, the dioxane absorption amount was measured for the products of the present invention and comparative products obtained after reaction drying, and the degree of porosity of the base was determined. The results are shown in Table 1. <Measurement method of dioxane absorption amount> Put 2 g of the base sample into a 300 ml beaker,
200g of dioxane was added to this and immersed for 24 hours. After immersion, excess dioxane was removed, and the sample was air-dried for 1 hour on a filter paper.The weight of the sample was measured, and the amount of dioxane absorbed was calculated using the following formula. X= W2 - W1 / W1 (g/g) However, X: Dioxane absorption amount (g/g) W1 : Sample collection amount (g) W2 : Sample weight after dioxane absorption (g)
【表】
実施例 2
マグネチツクスターラー、温度計を備えた300
ml容のビーカーに、第2表に示した各分子量のポ
リ−L−ラクチドの17.4gとクロロホルム161g
を入れ、30℃で撹はん溶解した。これにジステア
リン酸アルミニウムの2.6gをクロロホルムに分
散させ39gとした液を添加し、45℃で10分間反応
させた。反応後のゲル生成物を石油エーテルに浸
漬し、クロロホルムを除去した後、40℃3mmHg
で減圧乾燥させ、本発明の多孔性基剤を得た。
また比較のために、分子量350、25000のポリ−
L−ラクチドについても同様に反応を行い、基剤
を得た。
得られた本発明品、及び比較例品について走査
型電子顕微鏡観察とジオキサン吸収量の測定を行
い、結果を第2表に示した。[Table] Example 2 300 equipped with magnetic stirrer and thermometer
In a ml beaker, add 17.4 g of poly-L-lactide of each molecular weight shown in Table 2 and 161 g of chloroform.
and stirred at 30°C to dissolve. A solution obtained by dispersing 2.6 g of aluminum distearate in chloroform to make 39 g was added thereto, and the mixture was reacted at 45° C. for 10 minutes. After the reaction, the gel product was immersed in petroleum ether to remove chloroform, and then heated at 40°C and 3 mmHg.
The porous base of the present invention was obtained by drying under reduced pressure. For comparison, polyamides with molecular weights of 350 and 25,000
A similar reaction was carried out with L-lactide to obtain a base. The obtained products of the present invention and comparative products were observed with a scanning electron microscope and the amount of dioxane absorbed was measured, and the results are shown in Table 2.
【表】【table】
【表】
実施例 3
撹はん機、温度計、コンデンサーを備えた500
ml容のセパラブルフラスコに、グリコリド−L−
ラクチド共重縮合体(グリコリド/L−ラクチド
モル比2.1、数平均分子量2000)の18gとベンゼ
ン350gを入れ、50℃で加熱溶解した。
これに第3表に示した炭素数8以上の高級脂肪
酸のアルミニウム塩の所定量を、ベンゼン56gに
分散させた液を添加し、60℃で20分間撹はん下反
応を行つた。
反応後、生成物をフラスコから取り出し、30℃
3mmHgで減圧乾燥し、本発明の多孔性基剤を得
た。また比較のために、炭素数8以上の高級脂肪
酸のアルミニウム塩以外の他のアルミニウム塩に
ついて、前記と同様に反応及び減圧乾燥を行つ
た。これらを走査型電子顕微鏡で多孔質状態を観
察し、またジオキサン吸収量を測定した。
結果を第3表に示した。[Table] Example 3 500 equipped with stirrer, thermometer, and condenser
In a ml separable flask, add glycolide-L-
18 g of lactide copolycondensate (glycolide/L-lactide molar ratio 2.1, number average molecular weight 2000) and 350 g of benzene were added and dissolved by heating at 50°C. To this was added a solution in which a predetermined amount of aluminum salt of a higher fatty acid having 8 or more carbon atoms as shown in Table 3 was dispersed in 56 g of benzene, and a reaction was carried out at 60° C. for 20 minutes with stirring. After the reaction, remove the product from the flask and store at 30°C.
It was dried under reduced pressure at 3 mmHg to obtain a porous base of the present invention. For comparison, other aluminum salts than the aluminum salts of higher fatty acids having 8 or more carbon atoms were reacted and dried under reduced pressure in the same manner as described above. The porous state of these samples was observed using a scanning electron microscope, and the amount of dioxane absorbed was measured. The results are shown in Table 3.
【表】
実施例 4
実施例1で得た本発明の多孔性基剤、及び比較
例品を粉砕し、250〜420μmとなるように篩分し
た粉末4.5gに0.5gのブタンベン(P−アミノ安
息香酸n−ブチルエステル)を各粉末の溶媒吸収
限度量の範囲となるようにクロロホルムに展開し
た溶液を全量吸収させた。これを乾燥器中で20℃
8時間乾燥させ、クロロホルムを揮散除去した。
このブタンベン吸収後の基剤0.15gを300mlの
37℃PH7.4のりん酸緩衝液に浸漬し、300rpmで撹
はんを行いながら所定時間毎に、ブタンベンの溶
出量を吸光光度計で測定した。
結果を第4表に示した。[Table] Example 4 The porous base of the present invention obtained in Example 1 and the comparative example were crushed and sieved to a powder size of 250 to 420 μm.To 4.5 g of powder was added 0.5 g of butaneben (P-amino Benzoic acid n-butyl ester) was developed in chloroform so as to be within the solvent absorption limit of each powder, and the entire amount of the solution was absorbed. Place this in a dryer at 20℃
It was dried for 8 hours and the chloroform was removed by volatilization. After absorbing this butaneben, add 0.15g of the base to 300ml.
The sample was immersed in a phosphate buffer solution at 37°C and pH 7.4, and the amount of butaneben eluted was measured using an absorptiometer at predetermined intervals while stirring at 300 rpm. The results are shown in Table 4.
Claims (1)
リラクチド、ポリグリコリド、又はそれらの共重
縮合体と、炭素数8以上の高級脂肪酸のアルミニ
ウム塩とを、前記ポリマー量に対してアルミニウ
ム塩量が3〜20重量%の範囲となるように添加
し、反応させてなる多孔性基剤。1 Polylactide, polyglycolide, or a copolycondensate thereof having a number average molecular weight of 500 to 15,000 and an aluminum salt of a higher fatty acid having 8 or more carbon atoms are mixed in an organic solvent in an amount of aluminum salt relative to the amount of the polymer. A porous base material that is added and reacted in an amount ranging from 3 to 20% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61054335A JPS62209161A (en) | 1986-03-11 | 1986-03-11 | porous base |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61054335A JPS62209161A (en) | 1986-03-11 | 1986-03-11 | porous base |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62209161A JPS62209161A (en) | 1987-09-14 |
| JPH0428020B2 true JPH0428020B2 (en) | 1992-05-13 |
Family
ID=12967730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61054335A Granted JPS62209161A (en) | 1986-03-11 | 1986-03-11 | porous base |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62209161A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284628A (en) * | 2006-04-20 | 2007-11-01 | Arakawa Chem Ind Co Ltd | Metal soap, method for producing the same and oil-absorbing material |
| US20100068169A1 (en) * | 2007-02-23 | 2010-03-18 | University Of The Witwatersrand, Johannesburg | Monolithic drug delivery system |
-
1986
- 1986-03-11 JP JP61054335A patent/JPS62209161A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62209161A (en) | 1987-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4624256A (en) | Caprolactone polymers for suture coating | |
| EP0270987B1 (en) | Process for preparation of catalyst-free resorbable homopolymers and copolymers. | |
| EP0376656B1 (en) | Absorbable coating and blend | |
| DE69421338T2 (en) | Copolymers of aromatic anhydrides and aliphatic esters | |
| JP4376455B2 (en) | Polyhydroxyalkanoate composition having controlled degradation rate | |
| DE69734905T2 (en) | Absorbable polyoxaamide-containing mixtures | |
| US5264540A (en) | Aromatic polyanhydrides | |
| AU784171B2 (en) | Compositions and medical devices utilizing bioabsorbable polymeric waxes | |
| Ramchandani et al. | The influence of manufacturing procedure on the degradation of poly (lactide-co-glycolide) 85: 15 and 50: 50 implants | |
| HU197032B (en) | Process for producing polyesters | |
| CA2452952A1 (en) | Compositions and medical devices utilizing bioabsorbable polymeric waxes | |
| JPS63255068A (en) | Implant piece | |
| NO771902L (en) | USUALLY SOLID, BIOABSORBABLE, HYDROLYZABLE, POLYMERED REACTION PRODUCT, AND PROCEDURES FOR THE PRODUCTION OF SUCH | |
| JPH0613602B2 (en) | Method for producing d-l-lactic acid-glycolic acid copolymer | |
| Bikiaris et al. | Novel biodegradable polyester poly (propylene succinate): synthesis and application in the preparation of solid dispersions and nanoparticles of a water-soluble drug | |
| US5187150A (en) | Polyester-based composition for the controlled release of polypeptide medicinal substances | |
| Adamus et al. | Degradation of nerve guidance channels based on a poly (L-lactic acid) poly (trimethylene carbonate) biomaterial | |
| EP1339776B1 (en) | Polyanhydrides | |
| JPH0428020B2 (en) | ||
| Śmiga‐Matuszowicz et al. | Isosorbide‐based polysebacates as polymeric components for development of in situ forming implants | |
| JP2002505359A (en) | Biodegradable polymers based on naturally occurring renewable raw materials, especially isosorbitol | |
| BE1001687A5 (en) | Based composition for polyesters controlled release of drug substances. | |
| JPH0564982B2 (en) | ||
| JPH0323100B2 (en) | ||
| JP2004533494A (en) | Method for producing polyester having free acid functional groups in the chain |